- MIME Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Mimecast (MIME) Financial statements
Company Profile
Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Cost of Revenue | |||||||
Gross Profit | |||||||
Gross Profit Margin (%) | |||||||
R&D Expense | |||||||
SG&A Expense | |||||||
Total Operating Expenses | |||||||
Operating Income or Loss | |||||||
Operating Margin (%) | |||||||
Interest Expense | |||||||
Total Other Income/Expenses | |||||||
Income Before Tax | |||||||
Income Tax Expense | |||||||
Income from Continuing Ops. | |||||||
Net Income | |||||||
Net Profit Margin (%) | |||||||
Net Income Available to Common Shareholders | |||||||
Basic EPS | |||||||
Diluted EPS | |||||||
Basic Average Shares | |||||||
Diluted Average Shares |
Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||||||
Cost of Revenue | |||||||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit Margin (%) | |||||||||||||||||||
R&D Expense | |||||||||||||||||||
SG&A Expense | |||||||||||||||||||
Total Operating Expenses | |||||||||||||||||||
Operating Income or Loss | |||||||||||||||||||
Operating Margin (%) | |||||||||||||||||||
Interest Expense | |||||||||||||||||||
Total Other Income/Expenses | |||||||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income from Continuing Ops. | |||||||||||||||||||
Net Income | |||||||||||||||||||
Net Profit Margin (%) | |||||||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||||||
Basic EPS | |||||||||||||||||||
Diluted EPS | |||||||||||||||||||
Basic Average Shares | |||||||||||||||||||
Diluted Average Shares |
Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|
Current Assets | |||||||
Cash & Cash Equivalents | |||||||
Marketable Securities | |||||||
Receivables | |||||||
Inventories | |||||||
Other Current Assets | |||||||
Total Current Assets | |||||||
Non-Current Assets | |||||||
Marketable Securities | |||||||
PPE Net | |||||||
Intangibles inc. Goodwill | |||||||
Other Non-Current Assets | |||||||
Total Non-Current Assets | |||||||
Total Assets | |||||||
Current Liabilities | |||||||
Accounts Payable | |||||||
Deferred Revenues | |||||||
Debt, Current | |||||||
Accrued Liabilities | |||||||
Other Current Liabilities | |||||||
Total Current Liabilities | |||||||
Non-Current Liabilities | |||||||
Deferred Revenues | |||||||
Debt, Non-Current | |||||||
Other Non-Current Liabilities | |||||||
Total Non-Current Liabilities | |||||||
Total Liabilities | |||||||
Shareholders' Equity | |||||||
Common Stock | |||||||
Additional Paid-In Capital | |||||||
Retained Earnings | |||||||
Other Shareholders' Equity | |||||||
Total Shareholders' Equity | |||||||
Total Liabilities & Shareholders' Equity |
Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||||||
Cash & Cash Equivalents | |||||||||||||||||||
Marketable Securities | |||||||||||||||||||
Receivables | |||||||||||||||||||
Inventories | |||||||||||||||||||
Other Current Assets | |||||||||||||||||||
Total Current Assets | |||||||||||||||||||
Non-Current Assets | |||||||||||||||||||
Marketable Securities | |||||||||||||||||||
PPE Net | |||||||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||||||
Other Non-Current Assets | |||||||||||||||||||
Total Non-Current Assets | |||||||||||||||||||
Total Assets | |||||||||||||||||||
Current Liabilities | |||||||||||||||||||
Accounts Payable | |||||||||||||||||||
Deferred Revenues | |||||||||||||||||||
Debt, Current | |||||||||||||||||||
Accrued Liabilities | |||||||||||||||||||
Other Current Liabilities | |||||||||||||||||||
Total Current Liabilities | |||||||||||||||||||
Non-Current Liabilities | |||||||||||||||||||
Deferred Revenues | |||||||||||||||||||
Debt, Non-Current | |||||||||||||||||||
Other Non-Current Liabilities | |||||||||||||||||||
Total Non-Current Liabilities | |||||||||||||||||||
Total Liabilities | |||||||||||||||||||
Shareholders' Equity | |||||||||||||||||||
Common Stock | |||||||||||||||||||
Additional Paid-In Capital | |||||||||||||||||||
Retained Earnings | |||||||||||||||||||
Other Shareholders' Equity | |||||||||||||||||||
Total Shareholders' Equity | |||||||||||||||||||
Total Liabilities & Shareholders' Equity |
Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||
Net Income | |||||||
Depreciation & Amortization | |||||||
Deferred Income Taxes | |||||||
Stock Based Compensation | |||||||
Accounts Receivable | |||||||
Inventory | |||||||
Accounts Payable | |||||||
Deferred Revenue | |||||||
Other Non-Cash | |||||||
Operating Cash Flow | |||||||
Cash Flows from Investing Activities | |||||||
PPE Investments | |||||||
Net Acquisitions | |||||||
Purchase of Investments | |||||||
Sale of Investments | |||||||
Other Investing Activity | |||||||
Investing Cash Flow | |||||||
Cash Flows from Financing Activities | |||||||
Debt Issued | |||||||
Proceeds from Debt Repayment | |||||||
Debt Repayment | |||||||
Proceeds from Sale of Equity | |||||||
Equity Repurchased | |||||||
Dividend Paid | |||||||
Other Financing Activity | |||||||
Financing Cash Flow | |||||||
Cash Position | |||||||
Beginning Cash Position | |||||||
End Cash Position | |||||||
Change in Cash | |||||||
Free Cash Flow | |||||||
Operating Cash Flow | |||||||
Capital Expenditure | |||||||
Free Cash Flow |
Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Mar 2017 | Mar 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||||||
Net Income | |||||||||||||||||||
Depreciation & Amortization | |||||||||||||||||||
Deferred Income Taxes | |||||||||||||||||||
Stock Based Compensation | |||||||||||||||||||
Accounts Receivable | |||||||||||||||||||
Inventory | |||||||||||||||||||
Accounts Payable | |||||||||||||||||||
Deferred Revenue | |||||||||||||||||||
Other Non-Cash | |||||||||||||||||||
Operating Cash Flow | |||||||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||||||
PPE Investments | |||||||||||||||||||
Net Acquisitions | |||||||||||||||||||
Purchase of Investments | |||||||||||||||||||
Sale of Investments | |||||||||||||||||||
Other Investing Activity | |||||||||||||||||||
Investing Cash Flow | |||||||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||||||
Debt Issued | |||||||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||||||
Debt Repayment | |||||||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||||||
Equity Repurchased | |||||||||||||||||||
Dividend Paid | |||||||||||||||||||
Other Financing Activity | |||||||||||||||||||
Financing Cash Flow | |||||||||||||||||||
Cash Position | |||||||||||||||||||
Beginning Cash Position | |||||||||||||||||||
End Cash Position | |||||||||||||||||||
Change in Cash | |||||||||||||||||||
Free Cash Flow | |||||||||||||||||||
Operating Cash Flow | |||||||||||||||||||
Capital Expenditure | |||||||||||||||||||
Free Cash Flow |